
浏览全部资源
扫码关注微信
上海中医药大学附属曙光医院肿瘤科(上海 201203)
支景琳,女,硕士研究生,主要从事中西医结合治疗肿瘤的研究工作
陈念芝,主治医师;E-mail: saber930607@163.com
收稿日期:2024-10-22,
纸质出版日期:2025-05-10
移动端阅览
支景琳,冯媛媛,刘宁宁,等.乌梅丸激活STING促进CD8+ T细胞浸润活化抗结直肠癌的机制[J].上海中医药杂志,2025,59(5):1-7.
ZHI Jinglin,FENG Yuanyuan,LIU Ningning,et al.Mechanism of Wumei Pill activating STING to promote CD8+ T cell infiltration and activation against colorectal cancer[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(5):1-7.
支景琳,冯媛媛,刘宁宁,等.乌梅丸激活STING促进CD8+ T细胞浸润活化抗结直肠癌的机制[J].上海中医药杂志,2025,59(5):1-7. DOI: 10.16305/j.1007-1334.2025.z20241022006.
ZHI Jinglin,FENG Yuanyuan,LIU Ningning,et al.Mechanism of Wumei Pill activating STING to promote CD8+ T cell infiltration and activation against colorectal cancer[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(5):1-7. DOI: 10.16305/j.1007-1334.2025.z20241022006.
目的
2
探讨乌梅丸对结直肠癌的抗癌能力和对T细胞表达的影响及其作用机制。
方法
2
采用皮下移植瘤构建法建立小鼠结直肠癌模型,然后随机将小鼠分为对照组(0.9%氯化钠溶液),乌梅丸低剂量组(20 g/kg)和乌梅丸高剂量组(40 g/kg);记录小鼠体质量、生存期、肿瘤体积以及肿瘤质量。随后采用苏木精-伊红(HE)染色法观察乌梅丸对小鼠结直肠肿瘤的影响,采用免疫组织化学染色法检测乌梅丸对小鼠肿瘤组织中细胞核增殖抗原-67(Ki67)表达的影响,结合流式细胞术分析乌梅丸对结直肠癌小鼠肿瘤组织中CD3
+
T细胞、CD4
+
T细胞、CD8
+
T细胞数量的影响,通过免疫荧光染色法观察乌梅丸对小鼠肿瘤组织中磷酸化干扰素刺激因子(p-STING)表达的影响,采用酶联免疫吸附分析(ELISA)法检测乌梅丸对小鼠血清中β干扰素(IFN-β)含量的影响,采用实时荧光定量逆转录聚合酶链式反应(RT-qPCR)法检测乌梅丸对小鼠肿瘤组织中
IFN
-
β
mRNA表达的影响。
结果
2
与对照组比较,乌梅丸干预可降低肿瘤质量和肿瘤体积,同时延长结直肠癌小鼠的生存期(
P
<
0.01)。HE染色和免疫组织化学染色法检测结果显示,与对照组相比,乌梅丸干预后肿瘤坏死部分明显增多,且肿瘤组织中Ki67表达降低(
P
<
0.01)。通过流式细胞术结果分析得出,与对照组相比,乌梅丸对肿瘤组织中CD3
+
T细胞和CD4
+
T细胞的数量无明显影响(
P
>
0.05),但却显著提高了CD8
+
T细胞的数量(
P
<
0.01)。同时,乌梅丸上调了结直肠癌小鼠肿瘤组织中p‑STING水平(
P
<
0.01),以及上调了血清及肿瘤组织中IFN-β的表达水平(
P
<
0.01)。
结论
2
乌梅丸可通过激活干扰素刺激因子(STING)信号通路促进肿瘤免疫微环境中CD8
+
T细胞的浸润,从而发挥抗结直肠癌的作用。
Objective
2
To investigate the effects of Wumei Pill on the anti-cancer ability and T cell expression of colorectal cancer and its potential mechanism.
Methods
2
Colorectal cancer mice model were established by subcutaneous tumor transplantation method, and then randomly divided into control group (0.9% sodium chloride solution), Wumei Pill low-dose group (20 g/kg) and Wumei Pill high-dose group (40 g/kg). The mass, survival time, tumor volume and tumor mass of the mice were recorded. Subsequently, the effect of Wumei Pill on colorectal tumors in mice was observed by hematoxylin-eosin
(HE) staining. The effect of Wumei Pill on nuclear proliferating antigen-67 (Ki67) expression in mouse tumor tissue was detected by immunohistochemistry staining. Flow cytometry was used to analyze the effects of Wumei Pill on the number of CD3
+
T cells, CD4
+
T cells and CD8
+
T cells in the tumor tissues of model mice. The effect of Wumei Pill on the expression of phosphorylated interferon stimulating factor (p-STING) in tumor tissue of mice was observed by immunofluorescence staining. The effect of Wumei Pill on serum interferon-β (IFN-β) content of mice was detected by enzyme-linked immunosorbent assay (ELISA). The effect of Wumei Pill on
IFN
-
β
mRNA expression in mouse tumor tissue was detected by real-time quantitative polymerase chain reaction (RT-qPCR).
Results
2
Wumei Pill decreased the mass and volume of tumor, and prolonged the survival time of colorectal cancer mice (
P
<
0.01). HE staining and immunohistochemistry staining results showed that the necrotic part of tumor increased significantly after Wumei Pill intervention compared with the control group, and Ki67 levels increased in tumor tissues (
P
<
0.01). Flow cytometry result showed that Wumei Pill had no significant effect on the number of CD3
+
T cells and CD4
+
T cells in tumor tissues (
P
>
0.05), but increased the number of CD8
+
T cells (
P
<
0.01). Wumei Pill up-regulated the level of p-STING in tumor tissues of colorectal cancer mice (
P
<
0.01), and up-regulated the expression level of IFN-β in serum and tumor tissues (
P
<
0.01).
Conclusions
2
Wumei Pill can promote the infiltration of CD8
+
T cells in tumor immune microenvironment by activating interferon stimulating factor (STING) signal pathway, so as to play an anti-colorectal cancer role.
ZHENG R , ZHANG S , ZENG H , et al . Cancer incidence and mortality in China,2016 [J]. J Natl Cancer Cent , 2022 , 2 ( 1 ): 1 - 9 .
中国医师协会癌症专业委员会 , 中国抗癌协会大肠癌专业委员会 , 国家癌症中心国家肿瘤质控中心结直肠癌质控专家委员会 . 结直肠癌靶向治疗中国专家共识 [J]. 中华结直肠疾病电子杂志 , 2022 , 11 ( 5 ): 353 - 360 .
田玉婷 , 张奇 , 潘新平 , 等 . 错配修复完整/微卫星稳定型结直肠癌放疗联合免疫治疗研究进展 [J]. 消化肿瘤杂志 (电子版), 2024 , 16 ( 2 ): 216 - 222 .
王钰涵 , 靳明明 , 吕昌莲 . 加减乌梅丸对结直肠癌治疗的研究进展 [J]. 中华中医药学刊 , 2024 , 42 ( 4 ): 184 - 188 .
FARHOOD B , NAJAFI M , MORTEZAEE K . CD8 + cytotoxic T lymphocytes in cancer immunotherapy: A review [J]. J Cell Physiol , 2019 , 234 ( 6 ): 8509 - 8521 .
DE VISSER K E , JOYCE J A . The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth [J]. Cancer Cell , 2023 , 41 ( 3 ): 374 - 403 .
KHOSRAVI G R , MOSTAFAVI S , BASTAN S , et al . Immunologic tumor microenvironment modulators for turning cold tumors hot [J]. Cancer Commun (Lond) , 2024 , 44 ( 5 ): 521 - 553 .
LIU Y T , SUN Z J . Turning cold tumors into hot tumors by improving T-cell infiltration [J]. Theranostics , 2021 , 11 ( 11 ): 5365 - 5386 .
HU Z , QU G , YU X , et al . Acylglycerol kinase maintains metabolic state and immune responses of CD8 + T cells [J]. Cell Metab , 2019 , 30 ( 2 ): 290 - 302 .
CHEN G , JIN Y , GUAN W L , et al . Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study [J]. Lancet Gastroenterol Hepatol , 2023 , 8 ( 5 ): 422 - 431 .
PAUL M S , OHASHI P S . The roles of CD8 + T cell subsets in antitumor immunity [J]. Trends Cell Biol , 2020 , 30 ( 9 ): 695 - 704 .
CHOW A , PERICA K , KLEBANOFF C A , et al . Clinical implications of T cell exhaustion for cancer immunotherapy [J]. Nat Rev Clin Oncol , 2022 , 19 ( 12 ): 775 - 790 .
GALON J , BRUNI D . Approaches to treat immune hot, altered and cold tumours with combination immunotherapies [J]. Nat Rev Drug Discov , 2019 , 18 ( 3 ): 197 - 218 .
郭栴子 , 杨小蒨 , 杨燕莹 , 等 . 从厥阴论治结直肠癌 [J]. 实用中医内科杂志 , 2020 , 34 ( 11 ): 10 - 13 .
张然 , 李素娟 , 陈正彦 , 等 . 基于Wnt通路加味乌梅丸对结肠癌的抑制机制 [J]. 世界中医药 , 2018 , 13 ( 8 ): 1972 - 1975 .
赵慧芳 . 基于PD-L1/PD-1通路乌梅丸治疗结直肠癌的作用机制研究 [D]. 天津 : 天津中医药大学 , 2023 .
QI Y , ZHANG Q , ZHU H . Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations [J]. Chin Med , 2019 , 14 : 1 - 22 .
吴柯 , 杨俊霞 , 周岐新 . 小檗碱对实验性大鼠结肠癌的防治作用与环氧化酶2关系的研究 [J]. 中国中药杂志 , 2010 , 35 ( 20 ): 2768 - 2773 .
温丽娜 , 韩宗强 . 以KRAS启动子G-四链体DNA为靶点的小檗碱对人结肠癌细胞SW620的作用及机制 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 12 ): 143 - 149 .
胡倩华 , 卢鑫 , 范志坤 , 等 . 人参皂苷Rg3治疗结肠癌的作用机制研究进展 [J]. 中药药理与临床 , 2023 , 39 ( 9 ): 123 - 128 .
ZHANG Y , HUANG L , SHI H , et al . Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance [J]. Cancer Sci , 2018 , 109 ( 1 ): 94 - 102 .
桂孟玹 , 黄彬 , 王瑞国 , 等 . 齐墩果酸通过调控IL-6/STAT3信号通路影响结肠癌细胞的增殖和凋亡 [J]. 中南药学 , 2021 , 19 ( 3 ): 444 - 449 .
CHEN Z J , TAN L L , FENG X , et al . Hydroxy-γ-sanshool from Zanthoxylum bungeanum (prickly ash) induces apoptosis of human colorectal cancer cell by activating P53 and Caspase 8 [J]. Front Nutr , 2022 , 9 : 914638 .
金虹 , 庞雪莹 , 刘小外 , 等 . 乌梅丸治疗恶性肿瘤的研究进展 [J]. 实用临床医药杂志 , 2021 , 25 ( 8 ): 129 - 132 .
王双瑛 , 杨子婧 , 孟宇航 , 等 . 乌梅丸古今文献分析 [J]. 中国中药杂志 , 2022 , 47 ( 14 ): 3956 - 3962 .
魏小曼 , 耿雪尘 , 李柳 , 等 . 基于癌毒病机理论的结直肠癌全程防治体系构建 [J]. 中华中医药杂志 , 2023 , 38 ( 2 ): 572 - 575 .
HOPFNER K P , HORNUNG V . Molecular mechanisms and cellular functions of cGAS-STING signalling [J]. Nat Rev Mol Cell Biol , 2020 , 21 ( 9 ): 501 - 521 .
SEN T , RODRIGUEZ B L , CHEN L , et al . Targeting DNA damage response promotes antitumor immunity through STING-mediated T‑cell activation in small cell lung cancer [J]. Cancer Discov , 2019 , 9 ( 5 ): 646 - 661 .
MAXWELL M B , HOM-TEDLA M S , YI J , et al . ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity [J]. Cell , 2024 , 187 ( 13 ): 3390 - 3408 .
LY M , CHEN M , ZHANG R , et al . Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy [J]. Cell Res , 2020 , 30 ( 11 ): 966 - 979 .
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构
沪公网安备 31011502015228号